Palvella Therapeutics Inc
PVLA
NASDAQ
Biotechnology
$156.13
USD
-0.42 (-0.27%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.24B
Volume 109.8K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics Inc | $2.48B | - | +23220.3% | - | |
KLRA | Kailera Therapeutics Inc | $2.46B | - | - | - | |
CDNA | CareDx Inc | $2.45B | 22.08 | +34.4% | - | |
PGEN | Precigen Inc | $2.33B | - | +1875.0% | - | |
MLYS | Mineralys Therapeutics Inc | $2.31B | - | - | - | |
VCEL | Vericel Corp | $2.26B | 93.45 | +22.9% | - | |
PVLA | Palvella Therapeutics Inc | $2.24B | - | -97.2% | - | |
ADMA | ADMA Biologics Inc | $2.19B | 12.97 | +8.0% | - | |
VERA | Vera Therapeutics, Inc | $2.16B | - | - | - |
Top Peer by Growth
Viridian Therapeutics Inc
+23220.3% YoY Revenue
Lowest P/E Ratio
ADMA Biologics Inc
12.97x P/E
Best 1-Year Return
CareDx Inc
+290.6% Return